MedPath

Ayurvedic treatment of Hypothyroidism by Kanchanar Guggul and Virechana Panchakarma.

Phase 2
Conditions
Health Condition 1: E039- Hypothyroidism, unspecified
Registration Number
CTRI/2019/07/020041
Lead Sponsor
Self Pavan Dnyandeo Sushir PG Kayachikitsa Scholar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients having clinical features of hypothyroidism and fulfilling diagnostic criteria.

2)The patient having serum thyroid stimulating hormone value in between 10µIU/ml to 50µIU/ml.

3)Patients of either gender, aged between 18- 60 years irrespective of caste, religion, socio economic and educational status.

4)Those patients of newly diagnosed with hypothyroidism who are willing to participate in trial and ready to give written consent.

5)Those who are fit for Virechana according to classics. [25]

6)Patients with controlled hypertension (Blood pressure <150/90mm of Hg) and diabetes mellitus (F <130mg/dl and PP <180mg/dl).

Exclusion Criteria

1)Patients not willing for trial.

2)Patients below 18 years and above 60 years.

3)Patients having uncontrolled hypertension, diabetes mellitus, Renal failure and any other systemic disease.

4)Patients suffering from congenital hypothyroidism, neoplasia, toxic goitre.

5)Patients on prolonged medication ( >6 weeks) with corticosteroid or any other drug that may have an influence on the outcome of study.

6)Pregnant females and lactating mothers.

7)Patients who are currently participating in other clinical trials (since last six months).

8)Patients who have under gone any type of thyroid surgery.

9)Those who are not fit for Virechana according to classics. [26]

10)Patient with noncompliance will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.To evaluate the efficacy of Virechana followed by Kanchanar Guggul on clinical <br/ ><br>features of hypothyroidism, thyroid function test, lipid profile and body mass index. <br/ ><br> <br/ ><br>Timepoint: 48-52 days
Secondary Outcome Measures
NameTimeMethod
To compare the efficacy of Virechana followed by Kanchanar Guggul with <br/ ><br>levothyroxine on clinical feature of hypothyroidism, thyroid function test, lipid profile <br/ ><br>and body mass indexTimepoint: In 48 to 52 days
© Copyright 2025. All Rights Reserved by MedPath